Use of selective serotonin re-uptake inhibitors and the heart rate corrected QT interval in a real-life setting: the population-based Rotterdam Study-Reference-Cited by-同舟云学术

Use of selective serotonin re-uptake inhibitors and the heart rate corrected QT interval in a real-life setting: the population-based Rotterdam Study

Published:2015-07-29 Issue:4 Volume:80 Page:698-705
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Maljuric Nevena M.¹,Noordam Raymond¹²,Aarts Nikkie¹²,Niemeijer Maartje N.¹,van den Berg Marten E.³,Hofman Albert¹,Kors Jan A.³,Stricker Bruno H.¹²⁴,Visser Loes E.¹²⁵

Affiliation:

1. Department of Epidemiology; Erasmus MC - University Medical Center Rotterdam; Rotterdam

2. Department of Internal Medicine; Erasmus MC - University Medical Center Rotterdam; Rotterdam

3. Department of Medical Informatics; Erasmus MC - University Medical Center Rotterdam; Rotterdam

4. Inspectorate of Health Care; Utrecht

5. Apotheek Haagse Ziekenhuizen - HAGA; The Hague the Netherlands

Funder

Netherlands Organisation for Health Research and Development

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12681/fullpdf

Reference44 articles.

1. Sudden cardiac death: epidemiology, transient risk, and intervention assessment;Myerburg;Ann Intern Med,1993

2. Frequency of sudden cardiac death and profiles of risk;Myerburg;Am J Cardiol,1997

3. Out-of-hospital cardiac arrest - the relevance of heart failure. The Maastricht Circulatory Arrest Registry;Gorgels;Eur Heart J,2003

4. Sudden cardiac death;Zipes;Circulation,1998

5. Drug-induced prolongation of the QT interval;Roden;N Engl J Med,2004

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential adverse events associated with sphingosine-1-phosphate (S1P) receptor modulators in patients with multiple sclerosis: an analysis of the FDA adverse event reporting system (FAERS) database;Frontiers in Pharmacology;2024-05-23

2. A Study of Sudden Cardiac Death in Schizophrenia;2024

3. Role of Pharmacokinetics and Pharmacogenetics of Antidepressant-Induced Prolongation of the QT Interval and Torsade de Pointes in Patients with Mental Disorders;Personalized Psychiatry and Neurology;2023-11-15

4. Polypharmacy and Potential Drug Interactions Causing Neurological Symptoms in Geriatric Patients with Epilepsy;ARCH EPILEPSY;2022

5. Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases;Frontiers in Pharmacology;2022-08-05